Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,206,951 papers from all fields of science
Search
Sign In
Create Free Account
Perifornical nucleus
Known as:
Nucleus perifornicalis
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Role of the Perifornical Hypothalamic Monoamine Neurotransmitter Systems in Anorectic Effects of Endotoxin
T. Adamson
,
C. Corll
,
F. Svec
,
J. Porter
Neuroendocrinology
2009
Corpus ID: 21217646
The cachexia-anorexia syndrome, in which patients suffering from chronic illness lack the desire to eat and experience weight…
Expand
2005
2005
Fos expression variances in mouse hypothalamus upon physical and osmotic stimuli: Co-staining with vasopressin, oxytocin, and tyrosine hydroxylase
Z. Pirnik
,
A. Kiss
Brain Research Bulletin
2005
Corpus ID: 25352712
Highly Cited
2003
Highly Cited
2003
Mitochondrial Complex Inhibitors Preferentially Damage Substantia Nigra Dopamine Neurons in Rat Brain Slices
P. Bywood
,
Stephen M. Johnson
Experimental Neurology
2003
Corpus ID: 22455276
Using a rat brain slice preparation, we investigated the role of energy impairment on the selective loss of dopamine neurons in…
Expand
1997
1997
[Role of substance P in pressor response of lateral hypothamus-perifornical region to glutamate].
Y. Wang
,
Y. Gu
,
Y. Lu
,
L. Li
,
L. Tan
Zhongguo ying yong sheng li xue za zhi = Zhongguo…
1997
Corpus ID: 9675141
Substance P(SP)-immunoreactive cell bodies, axon terminals and SP receptors were widely scattered in most pressor areas. Lateral…
Expand
1988
1988
Lateral hypothalamic dynorphinergic efferents to the amygdala and brainstem in the rat
A. Zardetto-Smith
,
M. Moga
,
D. Magnuson
,
T. Gray
Peptides
1988
Corpus ID: 77073
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE